Genome-wide association study in 8,956 German individuals identifies influence of ABO histo-blood groups on gut microbiome.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
02 2021
Historique:
received: 14 01 2020
accepted: 03 11 2020
pubmed: 20 1 2021
medline: 5 3 2021
entrez: 19 1 2021
Statut: ppublish

Résumé

The intestinal microbiome is implicated as an important modulating factor in multiple inflammatory

Identifiants

pubmed: 33462482
doi: 10.1038/s41588-020-00747-1
pii: 10.1038/s41588-020-00747-1
doi:

Substances chimiques

ABO Blood-Group System 0
Fucosyltransferases EC 2.4.1.-
Lactase EC 3.2.1.108

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-155

Références

Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655–662 (2019).
pubmed: 31142855 pmcid: 6650278 doi: 10.1038/s41586-019-1237-9
Franzosa, E. A. et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat. Microbiol. 4, 293–305 (2019).
pubmed: 30531976 doi: 10.1038/s41564-018-0306-4
Cryan, J. F., O’Riordan, K. J., Sandhu, K., Peterson, V. & Dinan, T. G. The gut microbiome in neurological disorders. Lancet Neurol. 19, 179–194 (2019).
pubmed: 31753762 doi: 10.1016/S1474-4422(19)30356-4
Wirbel, J. et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat. Med. 25, 679–689 (2019).
pubmed: 30936547 pmcid: 7984229 doi: 10.1038/s41591-019-0406-6
Blekhman, R. et al. Host genetic variation impacts microbiome composition across human body sites. Genome Biol. 16, 191 (2015).
pubmed: 26374288 pmcid: 4570153 doi: 10.1186/s13059-015-0759-1
Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789–799 (2014).
pubmed: 25417156 pmcid: 4255478 doi: 10.1016/j.cell.2014.09.053
Wang, J. et al. Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota. Nat. Genet. 48, 1396–1406 (2016).
pubmed: 27723756 pmcid: 5626933 doi: 10.1038/ng.3695
Turpin, W. et al. Association of host genome with intestinal microbial composition in a large healthy cohort. Nat. Genet. 48, 1413–1417 (2016).
pubmed: 27694960 doi: 10.1038/ng.3693
Bonder, M. J. et al. The effect of host genetics on the gut microbiome. Nat. Genet. 48, 1407–1412 (2016).
pubmed: 27694959 doi: 10.1038/ng.3663
Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210–215 (2018).
pubmed: 29489753 doi: 10.1038/nature25973
Goodrich, J. K. et al. Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe 19, 731–743 (2016).
pubmed: 27173935 pmcid: 4915943 doi: 10.1016/j.chom.2016.04.017
Krawczak, M. et al. PopGen: population-based recruitment of patients and controls for the analysis of complex genotype–phenotype relationships. Community Genet. 9, 55–61 (2006).
pubmed: 16490960
Völzke, H. [Study of Health in Pomerania (SHIP). Concept, design and selected results]. Bundesgesundheitsblatt—Gesundheitsforschung—Gesundheitsschutz 55, 790–794 (2012).
pubmed: 22736157 doi: 10.1007/s00103-012-1483-6
Völzke, H. et al. Cohort profile: the study of health in Pomerania. Int. J. Epidemiol. 40, 294–307 (2011).
pubmed: 20167617 doi: 10.1093/ije/dyp394
Holle, R., Happich, M., Löwel, H. & Wichmann, H. E., MONICA/KORA Study Group. KORA—a research platform for population based health research. Gesundheitswesen Bundesverb. 67, S19–S25 (2005).
doi: 10.1055/s-2005-858235
Reitmeier, S. et al. Arrhythmic gut microbiome signatures for risk profiling of type-2 diabetes. Cell Host Microbe 28, 258–272.e6 (2020).
pubmed: 32619440 doi: 10.1016/j.chom.2020.06.004
Johnson, J. S. et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat. Commun. 10, 5029 (2019).
pubmed: 31695033 pmcid: 6834636 doi: 10.1038/s41467-019-13036-1
Lozupone, C. & Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71, 8228–8235 (2005).
pubmed: 16332807 pmcid: 1317376 doi: 10.1128/AEM.71.12.8228-8235.2005
Davenport, E. R. et al. Genome-wide association studies of the human gut microbiota. PLoS ONE 10, e0140301 (2015).
pubmed: 26528553 pmcid: 4631601 doi: 10.1371/journal.pone.0140301
Wegiel, B. et al. Biliverdin inhibits Toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductase. Proc. Natl Acad. Sci. USA 108, 18849–18854 (2011).
pubmed: 22042868 pmcid: 3219137 doi: 10.1073/pnas.1108571108
Schirmer, M. et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell 167, 1125–1136.e8 (2016).
pubmed: 27814509 pmcid: 5131922 doi: 10.1016/j.cell.2016.10.020
McGovern, D. P. B. et al. Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn’s disease. Hum. Mol. Genet. 19, 3468–3476 (2010).
pubmed: 20570966 pmcid: 2916706 doi: 10.1093/hmg/ddq248
Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).
pubmed: 23128233 pmcid: 3491803 doi: 10.1038/nature11582
Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015).
pubmed: 26192919 pmcid: 4881818 doi: 10.1038/ng.3359
de Lange, K. M. et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat. Genet. 49, 256–261 (2017).
pubmed: 28067908 pmcid: 5289481 doi: 10.1038/ng.3760
Smith, G. D. & Ebrahim, S. Mendelian Randomization: Genetic Variants as Instruments for Strengthening Causal Inference in Observational Studies (National Academies Press, 2008).
Wade, K. H. & Hall, L. J. Improving causality in microbiome research: can human genetic epidemiology help? Wellcome Open Res. 4, 199 (2020).
pubmed: 32462081 pmcid: 7217228 doi: 10.12688/wellcomeopenres.15628.3
Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 7, e34408 (2018).
pubmed: 29846171 pmcid: 5976434 doi: 10.7554/eLife.34408
Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
pubmed: 21508958 pmcid: 3728647 doi: 10.1038/nature09944
Wu, G. D. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105–108 (2011).
pubmed: 21885731 pmcid: 3368382 doi: 10.1126/science.1208344
Costea, P. I. et al. Enterotypes in the landscape of gut microbial community composition. Nat. Microbiol. 3, 8–16 (2018).
pubmed: 29255284 doi: 10.1038/s41564-017-0072-8
Vieira-Silva, S. et al. Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses. Nat. Microbiol. 4, 1826–1831 (2019).
pubmed: 31209308 doi: 10.1038/s41564-019-0483-9
Zhou, Y. & Zhi, F. Lower level of bacteroides in the gut microbiota is associated with inflammatory bowel disease: a meta-analysis. BioMed. Res. Int. 2016, 5828959 (2016).
pubmed: 27999802 pmcid: 5143693 doi: 10.1155/2016/5828959
Wang, K. et al. Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep. 26, 222–235.e5 (2019).
pubmed: 30605678 doi: 10.1016/j.celrep.2018.12.028
Watanabe, K., Taskesen, E., van. Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
pubmed: 29184056 pmcid: 5705698 doi: 10.1038/s41467-017-01261-5
Davenport, E. R. et al. ABO antigen and secretor statuses are not associated with gut microbiota composition in 1,500 twins. BMC Genomics 17, 941 (2016).
pubmed: 27871240 pmcid: 5117602 doi: 10.1186/s12864-016-3290-1
Turpin, W. et al. FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects. Gut Microbes 9, 357–368 (2018).
pubmed: 29533703 pmcid: 6219652
Rausch, P. et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (secretor) genotype. Proc. Natl Acad. Sci. USA 108, 19030–19035 (2011).
pubmed: 22068912 pmcid: 3223430 doi: 10.1073/pnas.1106408108
Weiss, F. U. et al. Fucosyltransferase 2 (FUT2) non-secretor status and blood group B are associated with elevated serum lipase activity in asymptomatic subjects, and an increased risk for chronic pancreatitis: a genetic association study. Gut 64, 646–656 (2015).
pubmed: 25028398 doi: 10.1136/gutjnl-2014-306930
Godon, J. J., Zumstein, E., Dabert, P., Habouzit, F. & Moletta, R. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl. Environ. Microbiol. 63, 2802–2813 (1997).
pubmed: 9212428 pmcid: 168577 doi: 10.1128/aem.63.7.2802-2813.1997
Frost, F. et al. Impaired exocrine pancreatic function associates with changes in intestinal microbiota composition and diversity. Gastroenterology 156, 1010–1015 (2019).
pubmed: 30391469 doi: 10.1053/j.gastro.2018.10.047
Paré, G. et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 4, e1000118 (2008).
R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2014).
Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).
pubmed: 27214047 pmcid: 4927377 doi: 10.1038/nmeth.3869
Cole, J. R. et al. Ribosomal database project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 42, D633–D642 (2014).
pubmed: 24288368 doi: 10.1093/nar/gkt1244
McMurdie, P. J. & Holmes, S. phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).
pubmed: 23630581 pmcid: 3632530 doi: 10.1371/journal.pone.0061217
Edgar, R. C. Updating the 97% identity threshold for 16S ribosomal RNA OTUs. Bioinformatics 34, 2371–2375 (2018).
pubmed: 29506021 doi: 10.1093/bioinformatics/bty113
Rognes, T., Flouri, T., Nichols, B., Quince, C. & Mahé, F. VSEARCH: a versatile open source tool for metagenomics. Peer J. 4, e2584 (2016).
pubmed: 27781170 pmcid: 5075697 doi: 10.7717/peerj.2584
Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590–D596 (2013).
pubmed: 23193283 doi: 10.1093/nar/gks1219
Price, M. N., Dehal, P. S. & Arkin, A. P. FastTree 2—approximately maximum-likelihood trees for large alignments. PLoS ONE 5, e9490 (2010).
pubmed: 20224823 pmcid: 2835736 doi: 10.1371/journal.pone.0009490
Oksanen, J. et al. The vegan package. Community Ecol. Package 10, 631–637 (2007).
Zhou, J. & Ning, D. Stochastic community assembly: does it matter in microbial ecology? Microbiol. Mol. Biol. Rev. 81, e00002–e00017 (2017).
pubmed: 29021219 pmcid: 5706748 doi: 10.1128/MMBR.00002-17
Rühlemann, M. C. et al. Application of the distance-based F test in an mGWAS investigating β diversity of intestinal microbiota identifies variants in SLC9A8 (NHE8) and 3 other loci. Gut Microbes 9, 68–75 (2017).
pubmed: 28816579 pmcid: 5939986 doi: 10.1080/19490976.2017.1356979
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
pubmed: 20616382 pmcid: 2922887 doi: 10.1093/bioinformatics/btq340
Qin, Y. et al. Combined effects of host genetics and diet on human gut microbiota and incident disease in a single population cohort. Preprint at medRxiv https://doi.org/10.1101/2020.09.12.20193045 (2020).
Li, J. & Ji, L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95, 221–227 (2005).
pubmed: 16077740 doi: 10.1038/sj.hdy.6800717
Deeks, J. J., Higgins, J. P. & Altman, D. G. in Cochrane Handbook for Systematic Reviews of Interventions (eds. Higgins, J. P. T. & Green, S.) 243–296 (John Wiley & Sons, 2008).
Yarmolinsky, J. et al. Circulating selenium and prostate cancer risk: a Mendelian randomization analysis. J. Natl Cancer Inst. 110, 1035–1038 (2018).
pubmed: 29788239 pmcid: 6136927 doi: 10.1093/jnci/djy081

Auteurs

Malte Christoph Rühlemann (MC)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.

Britt Marie Hermes (BM)

Evolutionary Genomics, Max Planck Institute for Evolutionary Biology, Plön, Germany.
Institute of Experimental Medicine, Kiel University, Kiel, Germany.
Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.

Corinna Bang (C)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.

Shauni Doms (S)

Evolutionary Genomics, Max Planck Institute for Evolutionary Biology, Plön, Germany.
Institute of Experimental Medicine, Kiel University, Kiel, Germany.

Lucas Moitinho-Silva (L)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Department of Dermatology, Kiel University, Kiel, Germany.

Louise Bruun Thingholm (LB)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.

Fabian Frost (F)

Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.

Frauke Degenhardt (F)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.

Michael Wittig (M)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.

Jan Kässens (J)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany.

Frank Ulrich Weiss (FU)

Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.

Annette Peters (A)

Institute of Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany.
German Center for Diabetes Research, Neuherberg, Germany.

Klaus Neuhaus (K)

ZIEL-Institute for Food & Health, Technical University of Munich, Freising, Germany.

Uwe Völker (U)

Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.

Henry Völzke (H)

Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.

Georg Homuth (G)

Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.

Stefan Weiss (S)

Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.
Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.

Harald Grallert (H)

Institute of Epidemiology, Helmholtz Zentrum München, Neuherberg, Germany.

Matthias Laudes (M)

Department of Internal Medicine 1, Kiel University, Kiel, Germany.

Wolfgang Lieb (W)

Institute of Epidemiology, Kiel University, Kiel, Germany.

Dirk Haller (D)

ZIEL-Institute for Food & Health, Technical University of Munich, Freising, Germany.
Chair of Nutrition and Immunology, Technical University of Munich, Freising, Germany.

Markus M Lerch (MM)

Department of Medicine A, University Medicine Greifswald, Greifswald, Germany.

John F Baines (JF)

Evolutionary Genomics, Max Planck Institute for Evolutionary Biology, Plön, Germany.
Institute of Experimental Medicine, Kiel University, Kiel, Germany.

Andre Franke (A)

Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany. a.franke@mucosa.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH